Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00811
|
|||||
| Drug Name |
Alprenolol
|
|||||
| Synonyms |
1-(2-Allylphenoxy)-3-isopropylamino-2-propanol; 1-(o-Allylphenoxy)-3-(isopropylamino)-2-propanol; 1-(o-Allylphenoxy)-3-isopropylamino)-2-propanol; 1-(propan-2-ylamino)-3-(2-prop-2-enylphenoxy)propan-2-ol; 1-[2-(propen-2-ylphenoxy)]-3-(isopropylamino)propan-2-ol; Alfeprol; Alfeprol [Russian]; Alpheprol; Alprenolol (INN); Alprenolol [INN:BAN]; Alprenololum; Alprenololum [INN-Latin]; Apllobal (TN); Aptine (TN); Aptol (TN); Duriles (TN); Gubernal (TN); H-56-28; Regletin (TN); Yobir; Yobir (TN)
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | High blood pressure [ICD11: BA00] | Withdrawn | [1] | |||
| Therapeutic Class |
Antiarrhythmic Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C15H23NO2
|
|||||
| Canonical SMILES |
CC(C)NCC(COC1=CC=CC=C1CC=C)O
|
|||||
| InChI |
InChI=1S/C15H23NO2/c1-4-7-13-8-5-6-9-15(13)18-11-14(17)10-16-12(2)3/h4-6,8-9,12,14,16-17H,1,7,10-11H2,2-3H3
|
|||||
| InChIKey |
PAZJSJFMUHDSTF-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 13655-52-2
|
|||||
| Pharmaceutical Properties | Molecular Weight | 249.35 | Topological Polar Surface Area | 41.5 | ||
| Heavy Atom Count | 18 | Rotatable Bond Count | 8 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 3 | |||
| XLogP |
3.1
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
ChEBI:31191
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY. Nucleic Acids Res. 2018 Jan 4;46(D1):D1091-D1106. (familyId=563) | |||||
| 2 | A novel screening strategy to identify ABCB1 substrates and inhibitors. Naunyn Schmiedebergs Arch Pharmacol. 2009 Jan;379(1):11-26. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.